Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Donna, Mackinnon"'
Autor:
Antonia M. Di Castri, Donna M. Halperin, Lingyun Ye, Donna MacKinnon-Cameron, Melissa Kervin, Jennifer E. Isenor, Scott A. Halperin
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 7 (2022)
We explored perceptions of healthcare providers in Nova Scotia and New Brunswick about pharmacists as immunizers. Pharmacists’ scopes of practice are increasingly broadening to include immunization, and providers and policymakers may find meaning i
Externí odkaz:
https://doaj.org/article/abc9a681bf2542fb8a9940eb6719566b
Autor:
Joanne M. Langley, Soren Gantt, Caroline Quach, Julie A. Bettinger, Scott A. Halperin, Jill Mutch, Shelly A. McNeil, Brian J. Ward, Donna MacKinnon-Cameron, Lingyun Ye, Kim Marty, David Scheifele, Erin Brown, Joenel Alcantara
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 454-462 (2020)
Emergency vaccination programs often are needed to control outbreaks of meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) on college campuses. Such campaigns expend multiple campus and public health resources. We conducted a r
Externí odkaz:
https://doaj.org/article/04902ddb4cd3493d8cc5b35557392d91
Autor:
Karen Green, Irene Martin, Mark Loeb, Jason LeBlanc, May ElSherif, Lingyun Ye, Donna MacKinnon-Cameron, Ardith Ambrose, Todd F Hatchette, Amanda LS Lang, Hayley D Gillis, Walter H Demczuk, Craig LaFerriere, Melissa K Andrew, Guy Boivin, William Bowie, Jennie Johnstone, Anne McCarthy, Allison McGeer, Makeda Semret, Sylvie Trottier, Louis Valiquette, Duncan Webster, Shelly A McNeil
Publikováno v:
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
Background In Canada, 13-valent pneumococcal conjugate vaccine (PCV13) is recommended in childhood, in individuals at high risk of invasive pneumococcal disease (IPD) and in healthy adults aged ≥65 years for protection against vaccine-type IPD and
Externí odkaz:
https://doaj.org/article/89c02dc9740f4a5a8037a9d0017c7561
Autor:
Melissa K. Andrew, Vivek Shinde, Todd Hatchette, Ardith Ambrose, Guy Boivin, William Bowie, Ayman Chit, Gael Dos Santos, May ElSherif, Karen Green, François Haguinet, Scott A. Halperin, Barbara Ibarguchi, Jennie Johnstone, Kevin Katz, Joanne M. Langley, Jason LeBlanc, Mark Loeb, Donna MacKinnon-Cameron, Anne McCarthy, Janet McElhaney, Allison McGeer, Michaela K. Nichols, Jeff Powis, David Richardson, Makeda Semret, Grant Stiver, Sylvie Trottier, Louis Valiquette, Duncan Webster, Lingyun Ye, Shelly A. McNeil, on behalf of the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Serious Outcomes Surveillance Network and the Toronto Invasive Bacterial Diseases Network (TIBDN)
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background The Serious Outcomes Surveillance (SOS) Network was established to monitor seasonal influenza complications among hospitalized Canadian adults and to assess the effectiveness of influenza vaccination against severe outcomes. Here
Externí odkaz:
https://doaj.org/article/75098b1ac1204a7f8f454352b734c3f9
Autor:
Melissa K. Andrew, Judith Godin, Jason LeBlanc, Guy Boivin, Louis Valiquette, Allison McGeer, Janet E. McElhaney, Todd F. Hatchette, May ElSherif, Donna MacKinnon-Cameron, Kevin Wilson, Ardith Ambrose, Sylvie Trottier, Mark Loeb, Stephanie W. Smith, Kevin Katz, Anne McCarthy, Shelly A. McNeil
Publikováno v:
Canadian Geriatrics Journal. 25:183-196
BackgroundWe report characteristics and outcomes of adults admitted to Canadian Immunization Research Network (CIRN) Ser-ious Outcomes Surveillance (SOS) Network hospitals with COVID-19 in 2020. MethodsPatients with laboratory-confirmed COVID-19 admi
Autor:
Joanne Langley, Elodie Pastural, Scott Halperin, Shelly McNeil, May ElSherif, Donna MacKinnon-Cameron, Lingyun Ye, Cécile Grange, Valérie Thibodeau, Jean-François Cailhier, Rejean Lapointe, Janet McElhaney, Luis Martin, Marilène Bolduc, Marie-Eve Laliberté-Gagné, Denis Leclerc, Pierre Savard
Publikováno v:
Vaccines, Vol 8, Iss 3, p 393 (2020)
Inactivated influenza vaccines efficacy is variable and often poor. We conducted a phase 1 trial (NCT02188810), to assess the safety and immunogenicity of a novel nanoparticle Toll-like receptor 7/8 agonist adjuvant (Papaya Mosaic Virus) at different
Externí odkaz:
https://doaj.org/article/6ae59293899145529a59a95aa4621974
Autor:
Sunita, Mulpuru, Melissa K, Andrew, Lingyun, Ye, Todd, Hatchette, Jason, LeBlanc, May, El-Sherif, Donna, MacKinnon-Cameron, Shawn D, Aaron, Gonzalo G, Alvarez, Alan J, Forster, Ardith, Ambrose, Shelly A, McNeil
Publikováno v:
Influenza and other respiratory viruses. 16(6)
Seasonal respiratory viral infections are associated with exacerbations and morbidity among patients with COPD. The real-world clinical outcomes associated with seasonal viral infections are less well established among hospitalized patients.To estima
Autor:
Melissa Kervin, D. M. Halperin, Jennifer E. Isenor, Donna MacKinnon-Cameron, A. M. Di Castri, Scott A. Halperin, Lingyun Ye
Publikováno v:
Hum Vaccin Immunother
Vaccine coverage is below desired levels in Canada, despite National Advisory Committee on Immunization recommendations. One solution to improve coverage is to offer vaccines in pharmacies. We explore the awareness, attitudes, beliefs, and behaviors
Autor:
Caroline Quach, Donna MacKinnon-Cameron, Erin L Brown, Kim Marty, Jill Mutch, Joanne M. Langley, Lingyun Ye, Joenel Alcantara, Brian J. Ward, Soren Gantt, Scott A. Halperin, David W. Scheifele, Shelly A. McNeil, Julie A. Bettinger
Publikováno v:
Emerging Infectious Diseases. 26:454-462
Emergency vaccination programs often are needed to control outbreaks of meningococcal disease caused by Neisseria meningitidis serogroup B (MenB) on college campuses. Such campaigns expend multiple campus and public health resources. We conducted a r
Autor:
Scott A. Halperin, Luis Martin, Joanne M. Langley, Shelly A. McNeil, Sanaz Salehi, Thomas A. Penfound, James B. Dale, Robert L Stewart, Lingyun Ye, Donna MacKinnon-Cameron, Elodie Pastural, Gregory J. Hurley
Publikováno v:
Vaccine. 38:1384-1392
Background Streptococcus pyogenes (group A Streptococcus, Strep A) is a widespread pathogen that continues to pose a significant threat to human health. The development of a Strep A vaccine remains an unmet global health need. One of the major vaccin